EFFECT OF ZOLEDRONIC ACID AND PAMIDRONATE ON SKELETAL-RELATED EVENTS AND MORTALITY IN WOMEN WITH BONE METASTASES FROM BREAST CANCER IN A MANAGED CARE PLAN: A RETROSPECTIVE DATABASE ANALYSIS

被引：0
|
作者：
Henk, H. J. [2 ]
Kaura, S. [1 ]
机构：
[1] Novartis Pharmaceut, Florham Pk, NJ USA
[2] i3 Innovus, Eden Prairie, MN USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)71910-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A253 / A253
页数：1
相关论文
共 50 条
  • [41] Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival
    Christian B. van der Pol
    Mark E. Schweitzer
    Gina Di Primio
    Marcos L. Sampaio
    Ania Kielar
    Mark Clemons
    Arash Jaberi
    Breast Cancer Research and Treatment, 2014, 146 : 583 - 589
  • [42] Zoledronic acid reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer
    Kohno, N
    Aogi, K
    Minami, H
    Nakamura, S
    Asaga, T
    Iino, Y
    Watanabe, T
    Goessl, C
    Ohashi, Y
    Takashima, S
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S133 - S133
  • [43] Health care utilization and costs associated with skeletal-related events (SREs) in patients with breast cancer (BC) and bone metastases (BMets).
    Hagiwara, May
    Chung, Karen
    Delea, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [44] Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
    de la Piedra, C.
    Alcaraz, A.
    Bellmunt, J.
    Meseguer, C.
    Gomez-Caamano, A.
    Ribal, M. J.
    Vazquez, F.
    Anido, U.
    Samper, P.
    Esteban, E.
    Alvarez-Ossorio, J. L.
    Lara, P. C.
    San Jose, L. A.
    Contreras, J. A.
    del Alba, A. G.
    Gonzalez-Gragera, B.
    Tabernero, A. J.
    Gonzalez-Enguita, C.
    Fernandez, J. M.
    Garcia-Escudero, A.
    Gomez-Veiga, F.
    Mendez, M. J.
    Segarra, J.
    Virizuela, J. A.
    Carles, J.
    Lassa, A.
    Calderero, V.
    Constela, M.
    Delgado, D.
    Manas, A.
    Murias, A.
    Reynes, G.
    Rodriguez, B.
    Rubio, G.
    Sanchez, E.
    Unda, M.
    Solsona, E.
    Martinez-Javaloyas, J. M.
    Comet-Batlle, J.
    Quicios, C.
    Martin-Fernandez, M.
    Mahillo-Fernandez, I.
    Morote, J.
    BRITISH JOURNAL OF CANCER, 2013, 108 (12) : 2565 - 2572
  • [45] Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
    C de la Piedra
    A Alcaraz
    J Bellmunt
    C Meseguer
    A Gómez-Caamano
    M J Ribal
    F Vázquez
    U Anido
    P Samper
    E Esteban
    J L Álvarez-Ossorio
    P C Lara
    L A San José
    J A Contreras
    A G del Alba
    B González-Gragera
    A J Tabernero
    C González-Enguita
    J M Fernández
    A García-Escudero
    F Gómez-Veiga
    M J Méndez
    J Segarra
    J A Virizuela
    J Carles
    A Lassa
    V Calderero
    M Constela
    D Delgado
    A Mañas
    A Murias
    G Reynes
    B Rodriguez
    G Rubio
    E Sánchez
    M Unda
    E Solsona
    J M Martínez-Javaloyas
    J Comet-Batlle
    C Quicios
    M Martín-Fernández
    I Mahillo-Fernández
    J Morote
    British Journal of Cancer, 2013, 108 : 2565 - 2572
  • [46] Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
    Duran, I.
    Garzon, C.
    Sanchez, A.
    Garcia-Carbonero, I.
    Perez-Gracia, J. L.
    Segui-Palmer, M. A.
    Wei, R.
    Restovic, G.
    Gasquet, J. A.
    Gutierrez, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (03): : 322 - 329
  • [47] Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
    I. Durán
    C. Garzón
    A. Sánchez
    I. García-Carbonero
    J. L. Pérez-Gracia
    M. Á. Seguí-Palmer
    R. Wei
    G. Restovic
    J. A. Gasquet
    L. Gutiérrez
    Clinical and Translational Oncology, 2014, 16 : 322 - 329
  • [48] Health-economic review of zoledronic acid for the management of skeletal-related events in bone-metastatic prostate cancer
    Carter, John A.
    Botteman, Marc F.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (04) : 425 - 437
  • [49] Prevention of Skeletal-Related Events With Denosumab or Zoledronic Acid - Combined Analysis From 3 Registrational Trials
    Lipton, A.
    Fizazi, K.
    Stopeck, A. T.
    Henry, D. H.
    Brown, J. E.
    Saad, F.
    Yardley, D.
    Maroto, P.
    Ke, C.
    Jun, S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S240 - S240
  • [50] Risk of skeletal-related events (SREs) in patients with breast cancer (BC) and newly diagnosed metastases to bone.
    Taneja, Charu
    Lamerato, Lois
    Glass, Andrew
    Richert-Boe, Kathryn E.
    Edelsberg, John
    Wolff, Greg G.
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
12345